View ValuationQualisys Holding 将来の成長Future 基準チェック /36Qualisys Holding利益と収益がそれぞれ年間15.6%と6.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に23.3% 15.6%なると予測されています。主要情報15.6%収益成長率15.57%EPS成長率Electronic 収益成長35.3%収益成長率6.9%将来の株主資本利益率23.35%アナリストカバレッジLow最終更新日23 Jun 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • 5hLess than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Board Member Jenny Rosberg was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Jun 12Qualisys Holding AB Expands Markerless Motion Capture Portfolio with Prisma Pose Built for Biomechanics LabsQualisys Holding AB introduced Prisma Pose, a new engine that integrates markerless skeletal tracking directly into Qualisys Track Manager (QTM), eliminating the need for software for third-party biomechanics laboratories. Prisma Pose is proprietary Qualisys technology that expands the markerless portfolio with an offering that covers the company's full spectrum of needs across sport, clinical, and research. Prisma Pose is designed to give biomechanics laboratories a practical and accessible markerless tracking solution, with no need for additional software vendors or hardware investments. Alongside OnTraq, for performance analysis in elite sport, and purpose-built Qualisys' partnership with Theia for laboratories with more extensive requirements, Qualisys now offers a complete suite of markerless solutions, tailored to the needs and ambitions of each organization. Running markerless motion capture in a lab typically requires a second QTM-based software stack - a separate license and additional steps to align markerless output with optical, force plate, and EMG data. Prisma Pose brings the full markerless processing chain inside QTM, with automatic synchronization across all data streams and direct integration into existing Qualisys analysis modules and Web Reports. Support is covered under existing Qualisys plans. Prisma Pose engine integrated in QTM also powers OnTraq. Two years of real-world deployment of OnTraq have sharpened the understanding of what biomechanics labs need from markerless capture, and that experience is built directly into Prisma Pose. Prisma Pose is validated for the most common biomechanical assessment tasks - making it well suited for labs conducting routine movement assessments, rehabilitation research, and sports science studies. Biomechanics labs using QTM can access Prisma Pose as an add-on license in the Fourth Quarter of 2026 when it will be launched. Qualisys Holding AB will showcase QTM with Prisma Pose at the World Congress of Biomechanics and the International Society of Biomechanics in Sports conference in the summer, as well as at several regional events during the fall. Demand for markerless capture is growing as labs seek to reduce participant burden and reach populations where marker attachment is not practical. Unlike competitors who license markerless software, Qualisys Holding AB has developed its own proprietary engine, giving the company full control over its roadmap and a strong and independent position in the markerless segment. For Qualisys Holding AB, Prisma Pose represents incremental license add-on revenue from customers who have already made the primary hardware investment. With OnTraq, Prisma Pose, and through the Theia partnership, Qualisys Holding AB offers a differentiated product portfolio across the full markerless spectrum - one of the fastest-growing segments in human movement research.Reported Earnings • May 21First quarter 2026 earnings released: kr0.36 loss per share (vs kr0.12 profit in 1Q 2025)First quarter 2026 results: kr0.36 loss per share (down from kr0.12 profit in 1Q 2025). Revenue: kr45.4m (down 25% from 1Q 2025). Net loss: kr3.58m (down 402% from profit in 1Q 2025). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Electronic industry in Germany.お知らせ • Dec 20+ 4 more updatesQualisys Holding AB (publ) to Report Nine Months, 2026 Results on Nov 12, 2026Qualisys Holding AB (publ) announced that they will report nine months, 2026 results on Nov 12, 2026お知らせ • Nov 11Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026. Location: gothenburg Swedenお知らせ • May 14Qualisys Holding AB (publ) announces Annual dividend, payable on May 21, 2025Qualisys Holding AB (publ) announced Annual dividend of SEK 3.0000 per share payable on May 21, 2025, ex-date on May 15, 2025 and record date on May 16, 2025.お知らせ • Apr 14+ 1 more updateQualisys Holding AB (publ), Annual General Meeting, May 14, 2025Qualisys Holding AB (publ), Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time. Location: at the companys premises at, kvarnbergsgatan 2, gothenburg Sweden業績と収益の成長予測DB:R0A - アナリストの将来予測と過去の財務データ ( )SEK Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028299473645112/31/2027277412837112/31/202625232374513/31/2026250322234N/A12/31/2025269372031N/A9/30/2025260323645N/A6/30/2025268384453N/A3/31/2025264394552N/A12/31/2024254405462N/A12/31/2023249393042N/A12/31/2022233453338N/A12/31/2021180231721N/A12/31/2020145162026N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: R0Aの予測収益成長率 (年間15.6% ) は 貯蓄率 ( 1.9% ) を上回っています。収益対市場: R0Aの収益 ( 15.6% ) German市場 ( 16.9% ) よりも低い成長が予測されています。高成長収益: R0Aの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: R0Aの収益 ( 6.9% ) German市場 ( 6.6% ) よりも速いペースで成長すると予測されています。高い収益成長: R0Aの収益 ( 6.9% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: R0Aの 自己資本利益率 は、3年後には高くなると予測されています ( 23.3 %)成長企業の発掘7D1Y7D1Y7D1YTech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/24 08:56終値2026/06/24 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Qualisys Holding AB (publ) 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Jakob SöderblomDNB Carnegie Commissioned Research
Board Change • 5hLess than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Board Member Jenny Rosberg was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 12Qualisys Holding AB Expands Markerless Motion Capture Portfolio with Prisma Pose Built for Biomechanics LabsQualisys Holding AB introduced Prisma Pose, a new engine that integrates markerless skeletal tracking directly into Qualisys Track Manager (QTM), eliminating the need for software for third-party biomechanics laboratories. Prisma Pose is proprietary Qualisys technology that expands the markerless portfolio with an offering that covers the company's full spectrum of needs across sport, clinical, and research. Prisma Pose is designed to give biomechanics laboratories a practical and accessible markerless tracking solution, with no need for additional software vendors or hardware investments. Alongside OnTraq, for performance analysis in elite sport, and purpose-built Qualisys' partnership with Theia for laboratories with more extensive requirements, Qualisys now offers a complete suite of markerless solutions, tailored to the needs and ambitions of each organization. Running markerless motion capture in a lab typically requires a second QTM-based software stack - a separate license and additional steps to align markerless output with optical, force plate, and EMG data. Prisma Pose brings the full markerless processing chain inside QTM, with automatic synchronization across all data streams and direct integration into existing Qualisys analysis modules and Web Reports. Support is covered under existing Qualisys plans. Prisma Pose engine integrated in QTM also powers OnTraq. Two years of real-world deployment of OnTraq have sharpened the understanding of what biomechanics labs need from markerless capture, and that experience is built directly into Prisma Pose. Prisma Pose is validated for the most common biomechanical assessment tasks - making it well suited for labs conducting routine movement assessments, rehabilitation research, and sports science studies. Biomechanics labs using QTM can access Prisma Pose as an add-on license in the Fourth Quarter of 2026 when it will be launched. Qualisys Holding AB will showcase QTM with Prisma Pose at the World Congress of Biomechanics and the International Society of Biomechanics in Sports conference in the summer, as well as at several regional events during the fall. Demand for markerless capture is growing as labs seek to reduce participant burden and reach populations where marker attachment is not practical. Unlike competitors who license markerless software, Qualisys Holding AB has developed its own proprietary engine, giving the company full control over its roadmap and a strong and independent position in the markerless segment. For Qualisys Holding AB, Prisma Pose represents incremental license add-on revenue from customers who have already made the primary hardware investment. With OnTraq, Prisma Pose, and through the Theia partnership, Qualisys Holding AB offers a differentiated product portfolio across the full markerless spectrum - one of the fastest-growing segments in human movement research.
Reported Earnings • May 21First quarter 2026 earnings released: kr0.36 loss per share (vs kr0.12 profit in 1Q 2025)First quarter 2026 results: kr0.36 loss per share (down from kr0.12 profit in 1Q 2025). Revenue: kr45.4m (down 25% from 1Q 2025). Net loss: kr3.58m (down 402% from profit in 1Q 2025). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Electronic industry in Germany.
お知らせ • Dec 20+ 4 more updatesQualisys Holding AB (publ) to Report Nine Months, 2026 Results on Nov 12, 2026Qualisys Holding AB (publ) announced that they will report nine months, 2026 results on Nov 12, 2026
お知らせ • Nov 11Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026. Location: gothenburg Sweden
お知らせ • May 14Qualisys Holding AB (publ) announces Annual dividend, payable on May 21, 2025Qualisys Holding AB (publ) announced Annual dividend of SEK 3.0000 per share payable on May 21, 2025, ex-date on May 15, 2025 and record date on May 16, 2025.
お知らせ • Apr 14+ 1 more updateQualisys Holding AB (publ), Annual General Meeting, May 14, 2025Qualisys Holding AB (publ), Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time. Location: at the companys premises at, kvarnbergsgatan 2, gothenburg Sweden